Evidence map›Paper›PMID 39766159›Full record

ArticleCancers2024

Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients.

Ali T Arafa, Megan Ludwig, Onur Tuncer, Lily Kollitz, Ava Gustafson, Ella Boytim, Christine Luo, Barbara Sabal, Daniel Steinberger, Yingchun Zhao and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ali T ArafaMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0003-0460-3039
Megan LudwigDepartment of Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0003-3133-3679
Onur TuncerNuclear Medicine Division, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.ORCID 0000-0003-3345-9208
Lily KollitzNuclear Medicine Division, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Ava GustafsonMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Ella BoytimMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Christine LuoMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0009-0002-4504-0033
Barbara SabalNuclear Medicine Division, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Daniel SteinbergerNuclear Medicine Division, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.ORCID 0000-0002-7410-3630
Yingchun ZhaoMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Scott M DehmMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Zuzan CayciNuclear Medicine Division, Department of Radiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Justin HwangMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0003-1686-7103
Peter W VillaltaMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0002-0067-3083
Emmanuel S AntonarakisMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Justin M DrakeMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
AR Gene Rearrangements and AR Signaling in Prostate CancerR01CA174777 · NCI · UNIVERSITY OF MINNESOTA · PI Scott M. Dehm · 2013 to 2026
$4.9M
RET Regulation and Targeting in Neuroendocrine Prostate CancerR01CA269801 · NCI · UNIVERSITY OF MINNESOTA · PI Justin Michael Drake · 2022 to 2026
$2.2M
Mass Spectrometric Analytical Collaborations with Members of the Masonic Cancer Center of the University of MinnesotaR50CA211256 · NCI · UNIVERSITY OF MINNESOTA · PI Peter William Villalta · 2016 to 2026
$2.1M
Targeting early events in prostate cancer lineage plasticityR01CA270539 · NCI · UNIVERSITY OF MINNESOTA · PI Scott M. Dehm · 2023 to 2026
$1.8M
Dissecting mechanisms of sensitivity to B7-H3 (CD276)-targeted therapeutics in prostate cancer (PC)R37CA288972 · NCI · UNIVERSITY OF MINNESOTA · PI Justin H. Hwang · 2024 to 2026
$1.1M
Department of Pharmacology Basic/Clinical Pilot Research Award at the University of MinnesotaMasonic Cancer Center Cancer Research Translational Initiative (CRTI) Pilot GrantNCI NIH HHS P30 CA077598NCI NIH HHS R01 CA174777NCI NIH HHS R01 CA269801NCI NIH HHS R01 CA270539NCI NIH HHS R37 CA288972NCI NIH HHS R50 CA211256
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B7-H3extracellular vesiclesprostate cancerproteomicsPSMA

Identifiers

PMID39766159
PMCPMC11674840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.